Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication
- Status
- UNKNOWN
- Phase
- PHASE4
VEGF Signaling Promotes Cell Growth and Metastasis in Hepatocellular Carcinoma in a VEGF Receptor Mediated Pathway
- Status
- UNKNOWN
- Phase
- N/A
Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients.
- Status
- COMPLETED
- Phase
- N/A
Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein
- Status
- TERMINATED
- Phase
- PHASE3
Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent
- Status
- WITHDRAWN
- Phase
- NA
Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE3
Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)
- Status
- COMPLETED
- Phase
- NA
TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient
- Status
- UNKNOWN
- Phase
- PHASE2
Comparison of TACE Versus TACE/TACI Combination in Advanced Hepatocellular Carcinoma With Portal Vein Invasion
- Status
- WITHDRAWN
- Phase
- NA
Tremelimumab With Chemoembolization or Ablation for Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion
- Status
- COMPLETED
- Phase
- PHASE2
Hepatocellular Carcinoma Using Stereotactic Body Radiotherapy
- Status
- UNKNOWN
- Phase
- NA
Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC)
- Status
- COMPLETED
- Phase
- NA
P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma.
- Status
- UNKNOWN
- Phase
- PHASE2
Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3